Global Kidney Stone Therapy

Kidney Stone Therapy Comprehensive Study by Type (Non-invasive Therapy, Minimally Invasive Treatment, Others), Application (Clinic , Hospital , Others), Stone type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), Treatment type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy), Diagnosis (Ultrasound, Intravenous Pyelography (IVP) or Intravenous Urogram, CT Scan, X-Ray, Others) Players and Region - Global Market Outlook to 2030

Kidney Stone Therapy Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Kidney Stone Therapy
Kidney stones are framed in a person's kidneys when normal substances in the urine end up being exorbitantly thought. Right when this occurs, squander material can stay in the kidney or may descend through the urinary lot, in the long run dropping from the human body. The variables that are foreseen to move the development of the worldwide kidney stone market are the rising occurrence of urolithiasis, deficient nourishment admission, and negligibly obtrusive methods. Notwithstanding, the unfriendly impacts of extracorporeal stun wave lithotripsy prevent the development of the market during the figure time frame. Furthermore, urolithiasis is the purpose behind framing stones in the kidney, bladder, and urethra (urinary lot). Kidney stones are a purpose behind blood in the pee and torment in the mid-district, flank, or crotch. Kidney stones are found in 1 of every 20 people eventually in their life. The significant danger factors for kidney infection consolidate hypertension, diabetes, and a background marked by kidney disappointment inside the family that are significantly found in people that are age 60 or more seasoned. For example, as per the National Kidney Foundation, universally, in excess of 73 million grown-ups have hypertension, and 29 million grown-ups have high diabetes, which are the significant purposes behind urolithiasis.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Kidney Stone Therapy market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Direx Group (United States), GEMSS Co (United States), Inceler Medikal (Turkey), Richard Wolf (Germany), EMS Electro Medical Systems (Switzerland), Allenger (India), Jena Med Tech GmbH(United States), Novamedtek (Turkey), Boston Scientific Corporation(United States) and Dornier MedTech(United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Kidney Stone Therapy market by Type (Non-invasive Therapy, Minimally Invasive Treatment and Others), Application (Clinic , Hospital  and Others) and Region.



On the basis of geography, the market of Kidney Stone Therapy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Stone type, the sub-segment i.e. Calcium Oxalate Stones will boost the Kidney Stone Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Treatment type, the sub-segment i.e. Medications will boost the Kidney Stone Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Diagnosis, the sub-segment i.e. Ultrasound will boost the Kidney Stone Therapy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The growing adoption of technology and increased funding

Market Growth Drivers:
Increasing Incidences of Urolithiasis and Minimally Invasive Procedures are driving the growth of the market.

Restraints:
The high cost of the treatment

Opportunities:
Steady evolving healthcare sector.

Market Leaders and their expansionary development strategies
In December 2023, Calyxo, announced that it closed a USD 50 million Series D financing round to support its CVAC aspiration system for kidney stone removal.
In September 2019, Dornier MedTech, a global urology company and a leader in kidney stone management, launched the new OptiVision technology for the Dornier Delta III at the German Urology Congress (DGU) 2019 in Hamburg from 18-20 September 2019. OptiVision is the first image post-processing software designed specifically to improve stone treatment outcomes. The product will be immediately available in Europe.


Key Target Audience
Kidney Stone Therapy provider, Medical companies, Research and development (R&D) companies, Market research and consulting service providers and Potential investors

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Non-invasive Therapy
  • Minimally Invasive Treatment
  • Others
By Application
  • Clinic 
  • Hospital 
  • Others
By Stone type
  • Calcium Oxalate Stones
  • Uric Acid
  • Struvite Kidney Stones
  • Cystine Stones
  • Calcium Phosphate Stones

By Treatment type
  • Medications
  • Extracorporeal Shock Wave Lithotripsy
  • Ureteroscopy
  • Percutaneous Nephrolithotomy

By Diagnosis
  • Ultrasound
  • Intravenous Pyelography (IVP) or Intravenous Urogram
  • CT Scan
  • X-Ray
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidences of Urolithiasis and Minimally Invasive Procedures are driving the growth of the market.
    • 3.3. Market Trends
      • 3.3.1. The growing adoption of technology and increased funding
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Kidney Stone Therapy, by Type, Application, Stone type, Treatment type, Diagnosis and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Kidney Stone Therapy (Value)
      • 5.2.1. Global Kidney Stone Therapy by: Type (Value)
        • 5.2.1.1. Non-invasive Therapy
        • 5.2.1.2. Minimally Invasive Treatment
        • 5.2.1.3. Others
      • 5.2.2. Global Kidney Stone Therapy by: Application (Value)
        • 5.2.2.1. Clinic 
        • 5.2.2.2. Hospital 
        • 5.2.2.3. Others
      • 5.2.3. Global Kidney Stone Therapy by: Stone type (Value)
        • 5.2.3.1. Calcium Oxalate Stones
        • 5.2.3.2. Uric Acid
        • 5.2.3.3. Struvite Kidney Stones
        • 5.2.3.4. Cystine Stones
        • 5.2.3.5. Calcium Phosphate Stones
      • 5.2.4. Global Kidney Stone Therapy by: Treatment type (Value)
        • 5.2.4.1. Medications
        • 5.2.4.2. Extracorporeal Shock Wave Lithotripsy
        • 5.2.4.3. Ureteroscopy
        • 5.2.4.4. Percutaneous Nephrolithotomy
      • 5.2.5. Global Kidney Stone Therapy by: Diagnosis (Value)
        • 5.2.5.1. Ultrasound
        • 5.2.5.2. Intravenous Pyelography (IVP) or Intravenous Urogram
        • 5.2.5.3. CT Scan
        • 5.2.5.4. X-Ray
        • 5.2.5.5. Others
      • 5.2.6. Global Kidney Stone Therapy Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Kidney Stone Therapy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Direx Group (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GEMSS Co (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Inceler Medikal (Turkey)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Richard Wolf (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. EMS Electro Medical Systems (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Allenger (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Jena Med Tech GmbH(United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Novamedtek (Turkey)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Boston Scientific Corporation(United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Dornier MedTech(United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Kidney Stone Therapy Sale, by Type, Application, Stone type, Treatment type, Diagnosis and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Kidney Stone Therapy (Value)
      • 7.2.1. Global Kidney Stone Therapy by: Type (Value)
        • 7.2.1.1. Non-invasive Therapy
        • 7.2.1.2. Minimally Invasive Treatment
        • 7.2.1.3. Others
      • 7.2.2. Global Kidney Stone Therapy by: Application (Value)
        • 7.2.2.1. Clinic 
        • 7.2.2.2. Hospital 
        • 7.2.2.3. Others
      • 7.2.3. Global Kidney Stone Therapy by: Stone type (Value)
        • 7.2.3.1. Calcium Oxalate Stones
        • 7.2.3.2. Uric Acid
        • 7.2.3.3. Struvite Kidney Stones
        • 7.2.3.4. Cystine Stones
        • 7.2.3.5. Calcium Phosphate Stones
      • 7.2.4. Global Kidney Stone Therapy by: Treatment type (Value)
        • 7.2.4.1. Medications
        • 7.2.4.2. Extracorporeal Shock Wave Lithotripsy
        • 7.2.4.3. Ureteroscopy
        • 7.2.4.4. Percutaneous Nephrolithotomy
      • 7.2.5. Global Kidney Stone Therapy by: Diagnosis (Value)
        • 7.2.5.1. Ultrasound
        • 7.2.5.2. Intravenous Pyelography (IVP) or Intravenous Urogram
        • 7.2.5.3. CT Scan
        • 7.2.5.4. X-Ray
        • 7.2.5.5. Others
      • 7.2.6. Global Kidney Stone Therapy Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Kidney Stone Therapy: by Type(USD Million)
  • Table 2. Kidney Stone Therapy Non-invasive Therapy , by Region USD Million (2018-2023)
  • Table 3. Kidney Stone Therapy Minimally Invasive Treatment , by Region USD Million (2018-2023)
  • Table 4. Kidney Stone Therapy Others , by Region USD Million (2018-2023)
  • Table 5. Kidney Stone Therapy: by Application(USD Million)
  • Table 6. Kidney Stone Therapy Clinic  , by Region USD Million (2018-2023)
  • Table 7. Kidney Stone Therapy Hospital  , by Region USD Million (2018-2023)
  • Table 8. Kidney Stone Therapy Others , by Region USD Million (2018-2023)
  • Table 9. Kidney Stone Therapy: by Stone type(USD Million)
  • Table 10. Kidney Stone Therapy Calcium Oxalate Stones , by Region USD Million (2018-2023)
  • Table 11. Kidney Stone Therapy Uric Acid , by Region USD Million (2018-2023)
  • Table 12. Kidney Stone Therapy Struvite Kidney Stones , by Region USD Million (2018-2023)
  • Table 13. Kidney Stone Therapy Cystine Stones , by Region USD Million (2018-2023)
  • Table 14. Kidney Stone Therapy Calcium Phosphate Stones , by Region USD Million (2018-2023)
  • Table 15. Kidney Stone Therapy: by Treatment type(USD Million)
  • Table 16. Kidney Stone Therapy Medications , by Region USD Million (2018-2023)
  • Table 17. Kidney Stone Therapy Extracorporeal Shock Wave Lithotripsy , by Region USD Million (2018-2023)
  • Table 18. Kidney Stone Therapy Ureteroscopy , by Region USD Million (2018-2023)
  • Table 19. Kidney Stone Therapy Percutaneous Nephrolithotomy , by Region USD Million (2018-2023)
  • Table 20. Kidney Stone Therapy: by Diagnosis(USD Million)
  • Table 21. Kidney Stone Therapy Ultrasound , by Region USD Million (2018-2023)
  • Table 22. Kidney Stone Therapy Intravenous Pyelography (IVP) or Intravenous Urogram , by Region USD Million (2018-2023)
  • Table 23. Kidney Stone Therapy CT Scan , by Region USD Million (2018-2023)
  • Table 24. Kidney Stone Therapy X-Ray , by Region USD Million (2018-2023)
  • Table 25. Kidney Stone Therapy Others , by Region USD Million (2018-2023)
  • Table 26. South America Kidney Stone Therapy, by Country USD Million (2018-2023)
  • Table 27. South America Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 28. South America Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 29. South America Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 30. South America Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 31. South America Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 32. Brazil Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 33. Brazil Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 34. Brazil Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 35. Brazil Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 36. Brazil Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 37. Argentina Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 38. Argentina Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 39. Argentina Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 40. Argentina Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 41. Argentina Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 42. Rest of South America Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 43. Rest of South America Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 44. Rest of South America Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 45. Rest of South America Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 46. Rest of South America Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 47. Asia Pacific Kidney Stone Therapy, by Country USD Million (2018-2023)
  • Table 48. Asia Pacific Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 49. Asia Pacific Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 50. Asia Pacific Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 51. Asia Pacific Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 52. Asia Pacific Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 53. China Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 54. China Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 55. China Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 56. China Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 57. China Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 58. Japan Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 59. Japan Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 60. Japan Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 61. Japan Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 62. Japan Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 63. India Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 64. India Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 65. India Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 66. India Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 67. India Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 68. South Korea Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 69. South Korea Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 70. South Korea Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 71. South Korea Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 72. South Korea Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 73. Taiwan Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 74. Taiwan Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 75. Taiwan Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 76. Taiwan Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 77. Taiwan Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 78. Australia Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 79. Australia Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 80. Australia Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 81. Australia Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 82. Australia Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 84. Rest of Asia-Pacific Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 85. Rest of Asia-Pacific Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 86. Rest of Asia-Pacific Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 87. Rest of Asia-Pacific Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 88. Europe Kidney Stone Therapy, by Country USD Million (2018-2023)
  • Table 89. Europe Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 90. Europe Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 91. Europe Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 92. Europe Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 93. Europe Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 94. Germany Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 95. Germany Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 96. Germany Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 97. Germany Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 98. Germany Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 99. France Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 100. France Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 101. France Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 102. France Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 103. France Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 104. Italy Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 105. Italy Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 106. Italy Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 107. Italy Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 108. Italy Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 109. United Kingdom Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 110. United Kingdom Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 111. United Kingdom Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 112. United Kingdom Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 113. United Kingdom Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 114. Netherlands Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 115. Netherlands Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 116. Netherlands Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 117. Netherlands Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 118. Netherlands Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 119. Rest of Europe Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 120. Rest of Europe Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 121. Rest of Europe Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 122. Rest of Europe Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 123. Rest of Europe Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 124. MEA Kidney Stone Therapy, by Country USD Million (2018-2023)
  • Table 125. MEA Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 126. MEA Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 127. MEA Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 128. MEA Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 129. MEA Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 130. Middle East Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 131. Middle East Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 132. Middle East Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 133. Middle East Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 134. Middle East Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 135. Africa Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 136. Africa Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 137. Africa Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 138. Africa Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 139. Africa Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 140. North America Kidney Stone Therapy, by Country USD Million (2018-2023)
  • Table 141. North America Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 142. North America Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 143. North America Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 144. North America Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 145. North America Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 146. United States Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 147. United States Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 148. United States Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 149. United States Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 150. United States Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 151. Canada Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 152. Canada Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 153. Canada Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 154. Canada Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 155. Canada Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 156. Mexico Kidney Stone Therapy, by Type USD Million (2018-2023)
  • Table 157. Mexico Kidney Stone Therapy, by Application USD Million (2018-2023)
  • Table 158. Mexico Kidney Stone Therapy, by Stone type USD Million (2018-2023)
  • Table 159. Mexico Kidney Stone Therapy, by Treatment type USD Million (2018-2023)
  • Table 160. Mexico Kidney Stone Therapy, by Diagnosis USD Million (2018-2023)
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Kidney Stone Therapy: by Type(USD Million)
  • Table 172. Kidney Stone Therapy Non-invasive Therapy , by Region USD Million (2025-2030)
  • Table 173. Kidney Stone Therapy Minimally Invasive Treatment , by Region USD Million (2025-2030)
  • Table 174. Kidney Stone Therapy Others , by Region USD Million (2025-2030)
  • Table 175. Kidney Stone Therapy: by Application(USD Million)
  • Table 176. Kidney Stone Therapy Clinic  , by Region USD Million (2025-2030)
  • Table 177. Kidney Stone Therapy Hospital  , by Region USD Million (2025-2030)
  • Table 178. Kidney Stone Therapy Others , by Region USD Million (2025-2030)
  • Table 179. Kidney Stone Therapy: by Stone type(USD Million)
  • Table 180. Kidney Stone Therapy Calcium Oxalate Stones , by Region USD Million (2025-2030)
  • Table 181. Kidney Stone Therapy Uric Acid , by Region USD Million (2025-2030)
  • Table 182. Kidney Stone Therapy Struvite Kidney Stones , by Region USD Million (2025-2030)
  • Table 183. Kidney Stone Therapy Cystine Stones , by Region USD Million (2025-2030)
  • Table 184. Kidney Stone Therapy Calcium Phosphate Stones , by Region USD Million (2025-2030)
  • Table 185. Kidney Stone Therapy: by Treatment type(USD Million)
  • Table 186. Kidney Stone Therapy Medications , by Region USD Million (2025-2030)
  • Table 187. Kidney Stone Therapy Extracorporeal Shock Wave Lithotripsy , by Region USD Million (2025-2030)
  • Table 188. Kidney Stone Therapy Ureteroscopy , by Region USD Million (2025-2030)
  • Table 189. Kidney Stone Therapy Percutaneous Nephrolithotomy , by Region USD Million (2025-2030)
  • Table 190. Kidney Stone Therapy: by Diagnosis(USD Million)
  • Table 191. Kidney Stone Therapy Ultrasound , by Region USD Million (2025-2030)
  • Table 192. Kidney Stone Therapy Intravenous Pyelography (IVP) or Intravenous Urogram , by Region USD Million (2025-2030)
  • Table 193. Kidney Stone Therapy CT Scan , by Region USD Million (2025-2030)
  • Table 194. Kidney Stone Therapy X-Ray , by Region USD Million (2025-2030)
  • Table 195. Kidney Stone Therapy Others , by Region USD Million (2025-2030)
  • Table 196. South America Kidney Stone Therapy, by Country USD Million (2025-2030)
  • Table 197. South America Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 198. South America Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 199. South America Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 200. South America Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 201. South America Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 202. Brazil Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 203. Brazil Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 204. Brazil Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 205. Brazil Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 206. Brazil Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 207. Argentina Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 208. Argentina Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 209. Argentina Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 210. Argentina Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 211. Argentina Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 212. Rest of South America Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 213. Rest of South America Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 214. Rest of South America Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 215. Rest of South America Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 216. Rest of South America Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 217. Asia Pacific Kidney Stone Therapy, by Country USD Million (2025-2030)
  • Table 218. Asia Pacific Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 219. Asia Pacific Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 220. Asia Pacific Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 221. Asia Pacific Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 222. Asia Pacific Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 223. China Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 224. China Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 225. China Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 226. China Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 227. China Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 228. Japan Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 229. Japan Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 230. Japan Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 231. Japan Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 232. Japan Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 233. India Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 234. India Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 235. India Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 236. India Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 237. India Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 238. South Korea Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 239. South Korea Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 240. South Korea Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 241. South Korea Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 242. South Korea Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 243. Taiwan Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 244. Taiwan Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 245. Taiwan Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 246. Taiwan Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 247. Taiwan Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 248. Australia Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 249. Australia Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 250. Australia Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 251. Australia Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 252. Australia Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 253. Rest of Asia-Pacific Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 254. Rest of Asia-Pacific Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 255. Rest of Asia-Pacific Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 256. Rest of Asia-Pacific Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 257. Rest of Asia-Pacific Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 258. Europe Kidney Stone Therapy, by Country USD Million (2025-2030)
  • Table 259. Europe Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 260. Europe Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 261. Europe Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 262. Europe Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 263. Europe Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 264. Germany Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 265. Germany Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 266. Germany Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 267. Germany Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 268. Germany Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 269. France Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 270. France Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 271. France Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 272. France Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 273. France Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 274. Italy Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 275. Italy Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 276. Italy Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 277. Italy Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 278. Italy Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 279. United Kingdom Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 280. United Kingdom Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 281. United Kingdom Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 282. United Kingdom Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 283. United Kingdom Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 284. Netherlands Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 285. Netherlands Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 286. Netherlands Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 287. Netherlands Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 288. Netherlands Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 289. Rest of Europe Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 290. Rest of Europe Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 291. Rest of Europe Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 292. Rest of Europe Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 293. Rest of Europe Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 294. MEA Kidney Stone Therapy, by Country USD Million (2025-2030)
  • Table 295. MEA Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 296. MEA Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 297. MEA Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 298. MEA Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 299. MEA Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 300. Middle East Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 301. Middle East Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 302. Middle East Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 303. Middle East Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 304. Middle East Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 305. Africa Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 306. Africa Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 307. Africa Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 308. Africa Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 309. Africa Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 310. North America Kidney Stone Therapy, by Country USD Million (2025-2030)
  • Table 311. North America Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 312. North America Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 313. North America Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 314. North America Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 315. North America Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 316. United States Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 317. United States Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 318. United States Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 319. United States Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 320. United States Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 321. Canada Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 322. Canada Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 323. Canada Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 324. Canada Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 325. Canada Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 326. Mexico Kidney Stone Therapy, by Type USD Million (2025-2030)
  • Table 327. Mexico Kidney Stone Therapy, by Application USD Million (2025-2030)
  • Table 328. Mexico Kidney Stone Therapy, by Stone type USD Million (2025-2030)
  • Table 329. Mexico Kidney Stone Therapy, by Treatment type USD Million (2025-2030)
  • Table 330. Mexico Kidney Stone Therapy, by Diagnosis USD Million (2025-2030)
  • Table 331. Research Programs/Design for This Report
  • Table 332. Key Data Information from Secondary Sources
  • Table 333. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Kidney Stone Therapy: by Type USD Million (2018-2023)
  • Figure 5. Global Kidney Stone Therapy: by Application USD Million (2018-2023)
  • Figure 6. Global Kidney Stone Therapy: by Stone type USD Million (2018-2023)
  • Figure 7. Global Kidney Stone Therapy: by Treatment type USD Million (2018-2023)
  • Figure 8. Global Kidney Stone Therapy: by Diagnosis USD Million (2018-2023)
  • Figure 9. South America Kidney Stone Therapy Share (%), by Country
  • Figure 10. Asia Pacific Kidney Stone Therapy Share (%), by Country
  • Figure 11. Europe Kidney Stone Therapy Share (%), by Country
  • Figure 12. MEA Kidney Stone Therapy Share (%), by Country
  • Figure 13. North America Kidney Stone Therapy Share (%), by Country
  • Figure 14. Global Kidney Stone Therapy share by Players 2023 (%)
  • Figure 15. Global Kidney Stone Therapy share by Players (Top 3) 2023(%)
  • Figure 16. Global Kidney Stone Therapy share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Direx Group (United States) Revenue, Net Income and Gross profit
  • Figure 19. Direx Group (United States) Revenue: by Geography 2023
  • Figure 20. GEMSS Co (United States) Revenue, Net Income and Gross profit
  • Figure 21. GEMSS Co (United States) Revenue: by Geography 2023
  • Figure 22. Inceler Medikal (Turkey) Revenue, Net Income and Gross profit
  • Figure 23. Inceler Medikal (Turkey) Revenue: by Geography 2023
  • Figure 24. Richard Wolf (Germany) Revenue, Net Income and Gross profit
  • Figure 25. Richard Wolf (Germany) Revenue: by Geography 2023
  • Figure 26. EMS Electro Medical Systems (Switzerland) Revenue, Net Income and Gross profit
  • Figure 27. EMS Electro Medical Systems (Switzerland) Revenue: by Geography 2023
  • Figure 28. Allenger (India) Revenue, Net Income and Gross profit
  • Figure 29. Allenger (India) Revenue: by Geography 2023
  • Figure 30. Jena Med Tech GmbH(United States) Revenue, Net Income and Gross profit
  • Figure 31. Jena Med Tech GmbH(United States) Revenue: by Geography 2023
  • Figure 32. Novamedtek (Turkey) Revenue, Net Income and Gross profit
  • Figure 33. Novamedtek (Turkey) Revenue: by Geography 2023
  • Figure 34. Boston Scientific Corporation(United States) Revenue, Net Income and Gross profit
  • Figure 35. Boston Scientific Corporation(United States) Revenue: by Geography 2023
  • Figure 36. Dornier MedTech(United States) Revenue, Net Income and Gross profit
  • Figure 37. Dornier MedTech(United States) Revenue: by Geography 2023
  • Figure 38. Global Kidney Stone Therapy: by Type USD Million (2025-2030)
  • Figure 39. Global Kidney Stone Therapy: by Application USD Million (2025-2030)
  • Figure 40. Global Kidney Stone Therapy: by Stone type USD Million (2025-2030)
  • Figure 41. Global Kidney Stone Therapy: by Treatment type USD Million (2025-2030)
  • Figure 42. Global Kidney Stone Therapy: by Diagnosis USD Million (2025-2030)
  • Figure 43. South America Kidney Stone Therapy Share (%), by Country
  • Figure 44. Asia Pacific Kidney Stone Therapy Share (%), by Country
  • Figure 45. Europe Kidney Stone Therapy Share (%), by Country
  • Figure 46. MEA Kidney Stone Therapy Share (%), by Country
  • Figure 47. North America Kidney Stone Therapy Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Direx Group (United States)
  • GEMSS Co (United States)
  • Inceler Medikal (Turkey)
  • Richard Wolf (Germany)
  • EMS Electro Medical Systems (Switzerland)
  • Allenger (India)
  • Jena Med Tech GmbH(United States)
  • Novamedtek (Turkey)
  • Boston Scientific Corporation(United States)
  • Dornier MedTech(United States)
Select User Access Type

Key Highlights of Report


Mar 2024 216 Pages 83 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Kidney Stone Therapy Quantitative research analysis
Global Kidney Stone Therapy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Direx Group (United States), GEMSS Co (United States), Inceler Medikal (Turkey), Richard Wolf (Germany), EMS Electro Medical Systems (Switzerland), Allenger (India), Jena Med Tech GmbH(United States), Novamedtek (Turkey), Boston Scientific Corporation(United States) and Dornier MedTech(United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The growing adoption of technology and increased funding" is seen as one of major influencing trends for Kidney Stone Therapy Market during projected period 2023-2030.
The Kidney Stone Therapy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Kidney Stone Therapy Report?

Have a Query? Click Here

Other Related Reports

Urethral Stricture Comprehensive Study by Type (Posterior Urethral Stricture, Anterior Urethral Stricture), Application (Hospitals, Gastrointestinal Surgery Clinics, Ambulatory Surgical Centers, Othe...
$ 3750
Constipation Treatment Comprehensive Study by Application (Infants, Children), Medication (Opioids, Vitamin Supplements, Antiemetics, Drugs, Antacids, Diuretics), Constipation (Normal Transit Constip...
$ 3450
Bilirubin Blood Test Comprehensive Study by Type (Transcutaneous, Bench-top), Application (Disease Diagnose, Blood Routine Analysis, Disease Prevention, Others), End Use (Hospital, Clinic, Healthcare...
$ 3800
Clinical Laboratory Service Comprehensive Study by Application (Hematology, Urinalysis, Microbiology, Immunochemistry, Others), Tests (Blood Testing, Urine Testing, Oral Fluid Testing, Hair Testing, ...
$ 3450
Healthcare Claim Management Comprehensive Study by Type (Integrated Solutions, Standalone Solutions), Deployment Mode (Cloud-Based, On-Premise), Components (Software, Hardware, Services) Players and ...
$ 3500
Scoliosis Treatment Comprehensive Study by Type (Structural Scoliosis, Non-Structural Scoliosis), Treatment (Device, Surgery, Others) Players and Region - Global Market Outlook to 2030
$ 3500